Presenting Innovative Ideas for Unmet Needs

Contact us

Preventing Peritoneal Adhesion

What do we do at Akesion

Nordmark has acquired majority shares of Akesion - a young private biopharmaceutical company specialized in the development of novel and innovative therapeutics for the treatment of diseases with high unmet medical needs, thereby creating value for patients and investors. The company was founded in 2014 by an experienced management team in order to provide the commercial infrastructure for the founder’s research activities.

Along with Nordmark's expertise the team possesses significant expertise throughout the entire process of drug development and registration. In addition, the company has access to a wide network of specialists and advisors. The company structure ensures assignment of the best available resources to the developing needs of a drug project.



We look forward to hearing from you!


* Required field

Data protection notice

We treat your data confidentially. You can find more information in our privacy policy.

Data protection notice

We treat the data you provide as part of the contact request as confidential. You can find more information on data processing in our privacy policy.